Home    Back

 99. Chronic intestinal pseudo-obstruction
 [ 2 clinical trials,    6 drugs（DrugBank: 1 drug),    0 target gene / 0 target pathway ] 

Searched query = "Chronic intestinal pseudo obstruction", "Chronic idiopathic pseudo bowel obstruction"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement		Last_Refreshed_
on		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04118699November 1, 201911 November 2019Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 TrialEfficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Single Center, Randomized, Placebo Controlled, Double-blind Phase 2 TrialChronic Intestinal Pseudo-obstructionDrug: Rifaximin oral tablet;Drug: Placebo oral tabletYokohama City UniversityASKA Pharmaceutical Co., Ltd.Recruiting20 Years74 YearsAll12Phase 2Japan
2NCT00793247December 200819 February 2015Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)A Double-Blind, Placebo-Controlled, Cross-Over, Multiple (n=1) Trial to Evaluate the Effects of R093877 in Patients With Chronic Intestinal Pseudo-Obstruction (CIP).Chronic Intestinal Pseudo-ObstructionDrug: PRU-PLA-PRU-PLA;Drug: PLA-PRU-PLA-PRU;Drug: PLA-PRU-PRU-PLA;Drug: PRU-PLA-PLA-PRUMovetisNot recruiting18 YearsN/ABothPhase 2United Kingdom